: ATLA-201126-1

Report information:

Report ID ATLA-201126-1
Study name HCC IO
Study authors Joe Yeong's Lab
Summary

Immunohistochemical scoring of CD38 in the tumor microenvironment predicts responsiveness to anti-PD-1/PD-L1 immunotherapy in hepatocellular carcinoma (HCC). The study found that total CD38+ cell proportion and CD38+CD68+ macrophage density predicts responsiveness to immune checkpoint blockade more accurately than PD-L1 scoring or CD8+ T cell density. Image shows mIHC/IF of HCC tumor microenvironment stained with DNA, PD-L1, CD38 and CD68.

Reference https://jitc.bmj.com/content/8/2/e000987
Specimen type Human liver tissue
Submitted by:
Submitter Joey Jia Ying Lee
(ImmunoAtlas, Bioinformatics Institute, A*STAR)
Last updated 9 Jul, 2021 (Fri),
4:00 PM

Case and specimen information:

# Case ID Image number
1 ATLA20001 1